ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko00120	Primary bile acid biosynthesis	9/387	20/7206	3.35704697261e-07
ko04610	Complement and coagulation cascades	15/387	79/7206	1.55419601118e-05
ko05323	Rheumatoid arthritis	16/387	89/7206	1.67387371092e-05
ko04640	Hematopoietic cell lineage	13/387	64/7206	2.71264545432e-05
ko04060	Cytokine-cytokine receptor interaction	25/387	191/7206	2.83720225658e-05
ko00190	Oxidative phosphorylation	19/387	127/7206	4.18179981946e-05
ko04966	Collecting duct acid secretion	8/387	26/7206	4.27493058277e-05
ko00010	Glycolysis / Gluconeogenesis	13/387	74/7206	0.000132435744639
ko04630	Jak-STAT signaling pathway	18/387	132/7206	0.000223774888259
ko04380	Osteoclast differentiation	18/387	134/7206	0.000270792888878
ko04145	Phagosome	20/387	162/7206	0.000512757040924
ko05150	Staphylococcus aureus infection	8/387	36/7206	0.000515831574545
ko05144	Malaria	9/387	45/7206	0.000534333842444
ko04650	Natural killer cell mediated cytotoxicity	14/387	97/7206	0.00061825504361
ko04611	Platelet activation	19/387	163/7206	0.00122690056668
ko05224	Breast cancer	1/387	174/7206	0.00165844066235
ko04064	NF-kappa B signaling pathway	13/387	96/7206	0.00174772004169
ko00680	Methane metabolism	7/387	34/7206	0.00185845714996
ko04550	Signaling pathways regulating pluripotency of stem cells	1/387	165/7206	0.00234484681879
ko03013	RNA transport	1/387	166/7206	0.0023892075585
ko04146	Peroxisome	12/387	89/7206	0.00269561256932
ko00592	alpha-Linolenic acid metabolism	5/387	19/7206	0.00270592688908
ko05120	Epithelial cell signaling in Helicobacter pylori infection	12/387	92/7206	0.00356497177842
ko05340	Primary immunodeficiency	6/387	30/7206	0.004562974824
ko00380	Tryptophan metabolism	8/387	50/7206	0.00474356443467
ko00590	Arachidonic acid metabolism	8/387	52/7206	0.00605659477253
ko05110	Vibrio cholerae infection	9/387	63/7206	0.00608309792628
ko05152	Tuberculosis	19/387	187/7206	0.00739655326976
ko05310	Asthma	4/387	17/7206	0.011156162461
ko04137	Mitophagy - animal	10/387	82/7206	0.0119444730468
ko05200	Pathways in cancer	15/387	492/7206	0.0166689701049
ko05140	Leishmaniasis	9/387	75/7206	0.01838663274
ko05034	Alcoholism	5/387	238/7206	0.0185266993853
ko04666	Fc gamma R-mediated phagocytosis	13/387	122/7206	0.0225552205355
ko00051	Fructose and mannose metabolism	6/387	42/7206	0.0234925707755
ko01230	Biosynthesis of amino acids	10/387	85/7206	0.0240744511453
ko04110	Cell cycle	2/387	145/7206	0.0244593801182
ko04142	Lysosome	15/387	151/7206	0.0257854503451
ko05206	MicroRNAs in cancer	3/387	177/7206	0.0261966110899
ko01200	Carbon metabolism	13/387	128/7206	0.0262756189901
ko00030	Pentose phosphate pathway	5/387	32/7206	0.0264561662201
ko05203	Viral carcinogenesis	7/387	277/7206	0.0290071135234
ko05321	Inflammatory bowel disease (IBD)	7/387	56/7206	0.029215478056
ko04022	cGMP-PKG signaling pathway	19/387	216/7206	0.0307835705235
ko05215	Prostate cancer	1/387	111/7206	0.0309514566632
ko00620	Pyruvate metabolism	6/387	46/7206	0.035102766172
ko00362	Benzoate degradation	2/387	6/7206	0.0373659389082
ko04721	Synaptic vesicle cycle	9/387	80/7206	0.0386741564615
ko04660	T cell receptor signaling pathway	12/387	124/7206	0.0420118799778
ko05204	Chemical carcinogenesis	6/387	48/7206	0.0420843255416
ko04914	Progesterone-mediated oocyte maturation	1/387	104/7206	0.0447814017294
ko04932	Non-alcoholic fatty liver disease (NAFLD)	16/387	182/7206	0.0449846767022
ko04270	Vascular smooth muscle contraction	14/387	154/7206	0.0459258090324
ko01521	EGFR tyrosine kinase inhibitor resistance	1/387	106/7206	0.0459340832299
ko00982	Drug metabolism - cytochrome P450	5/387	37/7206	0.0461091874954
ko04139	Mitophagy - yeast	5/387	37/7206	0.0461091874954